Suppr超能文献

[我们对放射性药物软件有哪些期望?]

[What do we expect from Radiopharmacy software?].

作者信息

Blondeel-Gomes S, Peyronnet D, Le Meur C

机构信息

Département de radiopharmacologie, Institut Curie, 26, rue d'Ulm, 75005 Paris, France.

Radiopharmacie, CHU Caen, avenue de la Côte de nacre, 14033 Caen, France.

出版信息

Ann Pharm Fr. 2020 Jan;78(1):76-86. doi: 10.1016/j.pharma.2019.10.001. Epub 2019 Nov 2.

Abstract

The Radiopharmaceutical Health Products circuit or RHP (radiopharmaceutical drugs, radiopharmaceutical preparation and radioactive implantable medical devices) is a complex process that nowadays requires computerization. This circuit must be in accordance with both the legislation on medicinal products and the legislation on artificial radioelements. It is acknowledged that computerization of the circuit; possibly different within each organization, provides assistance to stakeholders: pharmaceutical analysis of prescription, pharmaceutical preparation and preparation of doses to be dispensed and waste management for example. The software also allows real-time monitoring of the activity and traceability of the various pharmaceutical processes. In addition, they are generally interfaced with equipment used routinely: dose calibrator, dose dispensing equipment. In the absence of any legislation for these software products, which are not considered either as medical devices or as software to assist prescription or dispensation, a working group, under the aegis of the Société Française de Radiopharmacie (SoFRa), has written a minimum set of specifications for these radiopharmaceutical software products. The analyses of the risk maps of different hospital structures allowed a global analysis and synthesis of the different processes, settings, interfaces and requirements for the proper use of these software. The specifications include the very specific requirements of radiopharmacy (notion of radioactive decay, complex preparations with chemical synthesis, traceability.) and will allow software publishers to propose tools adapted to our practice and the RHP circuit.

摘要

放射性药品保健产品流程(RHP,即放射性药品、放射性药物制剂和放射性可植入医疗器械)是一个复杂的过程,如今需要计算机化。该流程必须符合药品法规和人工放射性元素法规。人们认识到,该流程的计算机化(每个组织可能有所不同)能为利益相关者提供帮助,例如处方的药学分析、药物制剂和待分发剂量的配制以及废物管理。该软件还能对各种制药过程的活性进行实时监测并实现可追溯性。此外,它们通常与常规使用的设备相连,如剂量校准仪、剂量分发设备。由于这些软件产品既不被视为医疗器械,也不被视为辅助处方或配药的软件,目前尚无针对它们的任何法规,因此在法国放射药学协会(SoFRa)的支持下,一个工作组为这些放射性药品软件产品编写了一套最低限度的规范。对不同医院结构的风险图进行分析,有助于对这些软件的正确使用涉及的不同流程、设置、接口和要求进行全面分析和综合。这些规范包括放射药学的非常具体的要求(放射性衰变概念、化学合成的复杂制剂、可追溯性),将使软件开发商能够推出适合我们的实践和RHP流程的工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验